Concepts (194)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urinary Bladder, Neurogenic | 1 | 2023 | 60 | 0.860 |
Why?
|
| Bacteriuria | 1 | 2023 | 77 | 0.840 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2023 | 185 | 0.740 |
Why?
|
| Ureteral Obstruction | 4 | 2023 | 143 | 0.670 |
Why?
|
| Urinary Tract Infections | 1 | 2023 | 321 | 0.660 |
Why?
|
| Ureter | 4 | 2023 | 209 | 0.580 |
Why?
|
| Vesico-Ureteral Reflux | 4 | 2023 | 81 | 0.560 |
Why?
|
| Cryosurgery | 4 | 2005 | 167 | 0.560 |
Why?
|
| Kidney Pelvis | 3 | 2021 | 102 | 0.500 |
Why?
|
| Hypospadias | 3 | 2020 | 77 | 0.470 |
Why?
|
| Nephrectomy | 4 | 2018 | 779 | 0.450 |
Why?
|
| Carcinoma, Renal Cell | 9 | 2006 | 2326 | 0.440 |
Why?
|
| Kidney Neoplasms | 10 | 2006 | 3022 | 0.420 |
Why?
|
| Urethral Diseases | 2 | 2020 | 36 | 0.330 |
Why?
|
| Penis | 2 | 2020 | 123 | 0.290 |
Why?
|
| Prostate | 2 | 2017 | 1088 | 0.280 |
Why?
|
| Kidney Tubules, Collecting | 1 | 2005 | 27 | 0.260 |
Why?
|
| Laparoscopy | 4 | 2018 | 1225 | 0.230 |
Why?
|
| Urinalysis | 1 | 2023 | 84 | 0.220 |
Why?
|
| Catheter Ablation | 2 | 2005 | 620 | 0.210 |
Why?
|
| Urology | 1 | 2003 | 128 | 0.210 |
Why?
|
| Hydronephrosis | 3 | 2021 | 50 | 0.200 |
Why?
|
| Postoperative Complications | 4 | 2023 | 5542 | 0.200 |
Why?
|
| Urologic Neoplasms | 1 | 2003 | 188 | 0.200 |
Why?
|
| Penile Diseases | 1 | 2020 | 10 | 0.200 |
Why?
|
| Urinary Fistula | 1 | 2020 | 27 | 0.190 |
Why?
|
| Cutaneous Fistula | 1 | 2020 | 46 | 0.190 |
Why?
|
| Documentation | 1 | 2022 | 207 | 0.190 |
Why?
|
| Infant | 13 | 2022 | 13310 | 0.180 |
Why?
|
| Urologic Surgical Procedures | 4 | 2021 | 93 | 0.180 |
Why?
|
| Anesthetics | 1 | 2020 | 115 | 0.170 |
Why?
|
| Reoperation | 3 | 2020 | 1382 | 0.170 |
Why?
|
| Nerve Block | 1 | 2020 | 176 | 0.170 |
Why?
|
| Child | 13 | 2023 | 29154 | 0.160 |
Why?
|
| Hospitals, Pediatric | 2 | 2020 | 773 | 0.160 |
Why?
|
| Child, Preschool | 12 | 2023 | 16273 | 0.160 |
Why?
|
| Engineering | 1 | 2017 | 7 | 0.150 |
Why?
|
| Prostatic Diseases | 1 | 2017 | 30 | 0.150 |
Why?
|
| Anesthesia | 1 | 2020 | 296 | 0.150 |
Why?
|
| Equipment Design | 2 | 2018 | 1204 | 0.140 |
Why?
|
| Kidney Transplantation | 1 | 2023 | 755 | 0.140 |
Why?
|
| Spermatic Cord Torsion | 1 | 2016 | 9 | 0.140 |
Why?
|
| Nephrostomy, Percutaneous | 1 | 2016 | 55 | 0.140 |
Why?
|
| Hematuria | 1 | 2016 | 85 | 0.140 |
Why?
|
| Carbonic Anhydrases | 2 | 2006 | 44 | 0.130 |
Why?
|
| Abscess | 1 | 2017 | 177 | 0.130 |
Why?
|
| Cystitis | 1 | 2016 | 107 | 0.130 |
Why?
|
| Foreskin | 1 | 2015 | 8 | 0.130 |
Why?
|
| Anti-Retroviral Agents | 1 | 2016 | 148 | 0.130 |
Why?
|
| Urethra | 1 | 2015 | 144 | 0.130 |
Why?
|
| Hydrocolpos | 1 | 2014 | 3 | 0.130 |
Why?
|
| Operating Rooms | 1 | 2016 | 122 | 0.130 |
Why?
|
| Ureterocele | 1 | 2014 | 8 | 0.130 |
Why?
|
| Patient Transfer | 1 | 2016 | 137 | 0.130 |
Why?
|
| Ureteroscopy | 1 | 2014 | 46 | 0.130 |
Why?
|
| Specialties, Surgical | 1 | 2017 | 137 | 0.130 |
Why?
|
| Electronic Health Records | 1 | 2022 | 929 | 0.120 |
Why?
|
| Urogenital Abnormalities | 1 | 2016 | 174 | 0.120 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2017 | 308 | 0.120 |
Why?
|
| Skin Transplantation | 1 | 2015 | 173 | 0.120 |
Why?
|
| Retrospective Studies | 11 | 2023 | 37905 | 0.120 |
Why?
|
| Anti-Bacterial Agents | 2 | 2023 | 2992 | 0.110 |
Why?
|
| Renal Insufficiency | 1 | 2015 | 321 | 0.110 |
Why?
|
| Models, Animal | 2 | 2005 | 664 | 0.110 |
Why?
|
| Ultrasonic Therapy | 2 | 2003 | 55 | 0.110 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2020 | 1303 | 0.100 |
Why?
|
| Robotic Surgical Procedures | 1 | 2018 | 481 | 0.100 |
Why?
|
| Humans | 29 | 2023 | 261506 | 0.100 |
Why?
|
| Bone Marrow Transplantation | 1 | 2016 | 1581 | 0.100 |
Why?
|
| Staphylococcal Infections | 1 | 2017 | 672 | 0.100 |
Why?
|
| Treatment Outcome | 9 | 2023 | 32848 | 0.090 |
Why?
|
| DNA Copy Number Variations | 1 | 2016 | 1516 | 0.090 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2003 | 500 | 0.090 |
Why?
|
| Operative Time | 2 | 2020 | 217 | 0.080 |
Why?
|
| Male | 19 | 2020 | 123000 | 0.080 |
Why?
|
| Emergency Service, Hospital | 1 | 2016 | 1148 | 0.080 |
Why?
|
| Surgical Flaps | 1 | 2015 | 927 | 0.080 |
Why?
|
| Feasibility Studies | 2 | 2022 | 2292 | 0.080 |
Why?
|
| Pediatrics | 1 | 2017 | 1141 | 0.080 |
Why?
|
| Adolescent | 7 | 2023 | 31252 | 0.070 |
Why?
|
| Kidney | 1 | 2014 | 2146 | 0.070 |
Why?
|
| Kidney Calices | 1 | 2005 | 7 | 0.070 |
Why?
|
| Wound Healing | 2 | 2015 | 815 | 0.070 |
Why?
|
| Kidney Cortex | 1 | 2005 | 35 | 0.070 |
Why?
|
| Needles | 1 | 2005 | 107 | 0.060 |
Why?
|
| Incidence | 3 | 2020 | 5673 | 0.060 |
Why?
|
| Oxidoreductases | 1 | 2005 | 171 | 0.060 |
Why?
|
| Hot Temperature | 1 | 2005 | 281 | 0.060 |
Why?
|
| Risk Assessment | 1 | 2016 | 6869 | 0.060 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2004 | 178 | 0.060 |
Why?
|
| Necrosis | 1 | 2005 | 580 | 0.060 |
Why?
|
| Female | 15 | 2020 | 141928 | 0.060 |
Why?
|
| Dogs | 1 | 2005 | 1155 | 0.060 |
Why?
|
| Safety | 1 | 2005 | 465 | 0.060 |
Why?
|
| Cysts | 1 | 2004 | 197 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 5539 | 0.060 |
Why?
|
| Tomography, Emission-Computed | 1 | 2003 | 310 | 0.050 |
Why?
|
| Ultrasonography, Interventional | 1 | 2005 | 429 | 0.050 |
Why?
|
| Surgeons | 2 | 2020 | 519 | 0.050 |
Why?
|
| Constriction, Pathologic | 1 | 2023 | 310 | 0.050 |
Why?
|
| Quality Improvement | 2 | 2020 | 851 | 0.050 |
Why?
|
| Nurse Anesthetists | 1 | 2020 | 12 | 0.050 |
Why?
|
| Sacrococcygeal Region | 1 | 2020 | 37 | 0.050 |
Why?
|
| Training Support | 1 | 2020 | 29 | 0.050 |
Why?
|
| Anesthesia, Caudal | 1 | 2020 | 16 | 0.050 |
Why?
|
| Swine | 1 | 2005 | 1541 | 0.050 |
Why?
|
| Laser Therapy | 1 | 2005 | 411 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2003 | 624 | 0.050 |
Why?
|
| Anesthesiologists | 1 | 2020 | 49 | 0.050 |
Why?
|
| Endothelium, Vascular | 1 | 2005 | 891 | 0.050 |
Why?
|
| Hemorrhage | 1 | 2005 | 712 | 0.050 |
Why?
|
| Monocytes | 1 | 2004 | 788 | 0.040 |
Why?
|
| Pulmonary Alveoli | 1 | 2020 | 208 | 0.040 |
Why?
|
| Infant, Newborn | 3 | 2018 | 8223 | 0.040 |
Why?
|
| Adenoviridae | 1 | 2004 | 1459 | 0.040 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2003 | 489 | 0.040 |
Why?
|
| Cancer Vaccines | 1 | 2004 | 697 | 0.040 |
Why?
|
| Ambulatory Care | 1 | 2022 | 554 | 0.040 |
Why?
|
| Adipose Tissue | 1 | 2003 | 769 | 0.040 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2016 | 43 | 0.040 |
Why?
|
| PAX2 Transcription Factor | 1 | 2016 | 43 | 0.040 |
Why?
|
| Cystoscopy | 1 | 2016 | 88 | 0.040 |
Why?
|
| Administration, Intravesical | 1 | 2016 | 162 | 0.040 |
Why?
|
| Cicatrix | 1 | 2018 | 208 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2016 | 182 | 0.030 |
Why?
|
| Program Development | 1 | 2017 | 261 | 0.030 |
Why?
|
| Mentoring | 1 | 2017 | 87 | 0.030 |
Why?
|
| Morbidity | 1 | 2016 | 397 | 0.030 |
Why?
|
| Prognosis | 5 | 2016 | 21713 | 0.030 |
Why?
|
| Colpotomy | 1 | 2014 | 8 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2022 | 2218 | 0.030 |
Why?
|
| Patient Selection | 1 | 2003 | 2055 | 0.030 |
Why?
|
| Survival Rate | 4 | 2016 | 12221 | 0.030 |
Why?
|
| Texas | 2 | 2016 | 6311 | 0.030 |
Why?
|
| Triage | 1 | 2016 | 252 | 0.030 |
Why?
|
| Recurrence | 2 | 2018 | 4758 | 0.030 |
Why?
|
| Health Facilities | 1 | 2014 | 79 | 0.030 |
Why?
|
| Faculty, Medical | 1 | 2017 | 289 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2006 | 7222 | 0.030 |
Why?
|
| Cause of Death | 1 | 2016 | 752 | 0.030 |
Why?
|
| Pedigree | 1 | 2016 | 1890 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2020 | 9244 | 0.030 |
Why?
|
| Animals | 3 | 2006 | 59536 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 778 | 0.030 |
Why?
|
| United States | 2 | 2020 | 15433 | 0.030 |
Why?
|
| Bone Neoplasms | 1 | 2003 | 2576 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 14889 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 1265 | 0.020 |
Why?
|
| Internship and Residency | 1 | 2020 | 1375 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2016 | 2803 | 0.020 |
Why?
|
| Risk Factors | 2 | 2016 | 17523 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2016 | 1664 | 0.020 |
Why?
|
| Neoplasm Staging | 4 | 2004 | 13658 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2003 | 7551 | 0.020 |
Why?
|
| Carbonic Anhydrase IX | 1 | 2006 | 36 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2003 | 4557 | 0.020 |
Why?
|
| Brain Neoplasms | 1 | 2003 | 4849 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2005 | 10331 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2003 | 10035 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2016 | 3343 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 4549 | 0.020 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2004 | 25 | 0.020 |
Why?
|
| Disease Progression | 1 | 2015 | 6682 | 0.020 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 2796 | 0.010 |
Why?
|
| Disease-Free Survival | 2 | 2004 | 10001 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2006 | 2314 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2004 | 1213 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2004 | 1008 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2003 | 11538 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2004 | 709 | 0.010 |
Why?
|
| Time Factors | 1 | 2015 | 12926 | 0.010 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2004 | 1064 | 0.010 |
Why?
|
| Middle Aged | 5 | 2005 | 86204 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2004 | 1694 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2014 | 7702 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 2508 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2004 | 3536 | 0.010 |
Why?
|
| Young Adult | 1 | 2016 | 21445 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2003 | 1171 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2004 | 3033 | 0.010 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2016 | 6915 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2003 | 3981 | 0.010 |
Why?
|
| Aged | 3 | 2005 | 70117 | 0.010 |
Why?
|
| Cytokines | 1 | 2004 | 2809 | 0.010 |
Why?
|
| Adult | 3 | 2005 | 77950 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 7548 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2004 | 9180 | 0.010 |
Why?
|
| Phenotype | 1 | 2004 | 6295 | 0.010 |
Why?
|
| Algorithms | 1 | 2003 | 3890 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2004 | 3869 | 0.010 |
Why?
|
| Immunotherapy | 1 | 2004 | 3341 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 14551 | 0.010 |
Why?
|
| Mice | 1 | 2006 | 34495 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2004 | 29902 | 0.000 |
Why?
|